SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-09-000818
Filing Date
2009-03-12
Accepted
2009-03-12 16:46:51
Documents
11
Period of Report
2009-01-31

Document Format Files

Seq Description Document Type Size
1 PEREGRINE peregrine_10q-013109.htm 10-Q 1035584
2 LOAN AND SECURITY AGREEMENT peregrine_10q-ex10111.htm EX-10.111 517571
3 SECURED TERM PROMISSORY NOTE peregrine_10q-ex10112.htm EX-10.112 12338
4 SECURED TERM PROMISSORY NOTE peregrine_10q-ex10113.htm EX-10.113 12378
5 INTELLECTUAL PROPERTY SECURITY AGREEMENT peregrine_10q-ex10114.htm EX-10.114 39637
6 INTELLECTUAL PROPERTY SECURITY AGREEMENT peregrine_10q-ex10115.htm EX-10.115 176889
7 WARRANT TO PURCHASE STOCK peregrine_10q-ex10116.htm EX-10.116 90256
8 WARRANT TO PURCHASE STOCK peregrine_10q-ex10117.htm EX-10.117 89840
9 CERTIFICATION peregrine_10q-ex3101.htm EX-31.1 11431
10 CERTIFICATION peregrine_10q-ex3102.htm EX-31.2 11456
11 CERTIFICATION peregrine_10q-ex32.htm EX-32 12145
  Complete submission text file 0001019687-09-000818.txt   2011126
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 001-32839 | Film No.: 09676283
SIC: 2835 In Vitro & In Vivo Diagnostic Substances